期刊文献+

靶向型药物载体在抗肿瘤治疗中的研究进展 被引量:6

Development of Targeted Drug Carriers for Anti-cancer Therapy
下载PDF
导出
摘要 恶性肿瘤是一种严重威胁人类健康的常见病和多发病,是引起死亡的主要原因之一。近年来,抗肿瘤药物的靶向性研究越来越受到人们的重视。发展抗肿瘤药物的新型靶向载体,增加药物靶向性,提高生物利用度,降低毒副作用,是目前备受关注的课题。根据近年来文献,综述了一些新型的抗肿瘤药物载体,包括靶向的脂质体载药系统、纳米粒载药系统、微粒载药系统、胶束载药系统等,并分别总结了其颗粒大小、载药类型、载药模式及治疗效果等,为肿瘤的靶向给药研究提供思路。 Cancer is a kind of frequently-occurring disease that seriously threatening human health. In recent years, more and more attention is attracted to study on targeting anti-cancer drugs. Development of new targeted anticancer drugs, increase of bioavailability and decrease of toxicity are the key subjects which have been concerned currently. According to recent literatures, an overview of development on novel targeted drug carriers (particle size, drug type and model, encapsulation efficiency, inhibition rate), such as, liposome, nanoparticles, microspheres, microcap sules, micelles, is given to provide a way for more effective targeted anti-cancer therapy.
出处 《材料导报》 EI CAS CSCD 北大核心 2014年第3期60-65,共6页 Materials Reports
基金 国家自然科学基金(31000425) 重庆市自然科学基金(CSTC 2010BB5226)
关键词 靶向 抗肿瘤 药物载体 targeted, anti-cancer, drug carriers
  • 相关文献

参考文献50

  • 1Lubbe A S, Alexiou C, Bercemann C. Clinical application of magnetic drug targeting[J]. J Surgical Res, 2001, 95 (2) : 200. 被引量:1
  • 2Roseanu A, Florian P E, Moisei M, et al. Liposomalization of lactoferrin enhanced its anti-tumoral effects on melanoma cells[J]. Biometals,2010,23(3SD :485. 被引量:1
  • 3Lin Y L, Liu Y K, Tsai N M, et al. A Lipo-PEG-PEI com?plex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells[J]. Nanomed:Nanotechn,Biology,Med,2012,8(3) :318. 被引量:1
  • 4Iyer A K, Su Y, Feng J J, et al. The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma[J]. Biomate?rials, 2011, 32( 10): 2605. 被引量:1
  • 5Yan Z Q, Wang F, Wen Z v, et a1. Lyl+ l-conjugated PE?Gylated liposomes , A carrier system for targeted therapy of lymphatic metastatic tumor[J]. J Controlled Release, 2012, 157(1):118. 被引量:1
  • 6Takara K, Hatakeyama H, Kibria G, et a1. Size-controlled, dual-ligand modified liposomes that target the tumor vascu?lature show promise for use in drug-resistant cancer therapy[J]. J Controlled Release,2012,162(l):225. 被引量:1
  • 7Yonenaga N, Kenjo E, Asai T, et a1. RGD-based active tar?geting of novel polycation liposomes bearing siRNA for cancer treatment[]]' J Controlled Release, 2012,160 (2): 177. 被引量:1
  • 8Bandekar A, Karve S, Chang M Y, et a1. Antitumor effica?cy following the intracellular and interstitial release of lipo?somal doxorubicin[]]. Biomaterials, 2012,33 (7) : 4345. 被引量:1
  • 9Lehtinen J, Raki M, Bergstrom K A, et a1. Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma[]]. PLOS ONE, 2012,7(7): e41410. 被引量:1
  • 10Zheng M B, Yue C X, Ma Y F, et a1. Single-step assembly of OOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy[J]. ACS Nano,2013,7(3):2056. 被引量:1

同被引文献85

  • 1闫雪霏,杨晔,尹登科.两亲性多糖自组装胶束给药系统研究进展[J].中国生化药物杂志,2014,34(4):174-178. 被引量:5
  • 2巫冠中,张文平,吕正兵,刘国卿.新型磺酰脲类化合物G004对血管内皮细胞的保护作用[J].中国临床药理学与治疗学,2005,10(10):1156-1161. 被引量:2
  • 3方家椿.分子靶点和分子靶向抗肿瘤药研究进展[J].北京大学学报(医学版),2006,38(6):575-578. 被引量:12
  • 4Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect[J]. Adv Drug Deliver Rev, 2011, 63(3): 136-151. 被引量:1
  • 5Dosio F, Stella B, Arpicco S, et al. Macromolecules as taxane delivery systems[J]. Expert Opin Drug Del, 2011, 8(1): 33-55. 被引量:1
  • 6Wang Y, Yang X, Yang J, et al. Serf-assembled nanopartieles of methotrexate conjugated O-carboxymethyl ehitosan: Preparation, characterization and drug release behavior in vitro[J]. Carbohyd Polym, 2011, 86(4): 1665-1670. 被引量:1
  • 7Luo Q, Wang P, Miao Y, et al. A novel 5-fluorouracil prodrug using hydroxyethyl starch as a macromoleeular carrier for sustained release[J]. CarbohydPolym, 2012, 87(4): 2642-2647. 被引量:1
  • 8Bassi P, Volpe A, D' agostino D, et al. Paclitaxel-hyaluronic acid for iutravesical therapy of bacillus Calmette-Guerin refractory carcinoma in situ of the bladder: Results of a phase I study[J]. J Urology, 2011, 185(2): 445-449. 被引量:1
  • 9Danhauser-Riedl S, Hausmann E, Schick HI), et al. Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD- 70, DOX-OXD)[J].InvestNewI)rug, 1993, 11(2): 187-195. 被引量:1
  • 10Luo XM, Chen MH, Zhang Y, et al. Pharmacokinetics and antitumor efficacy of micelles assembled from muhiarmed amphiphilic copolymers with drug conjugates in comparison with drug-encapsulated micelles[J]. EurJ Pharm Biopharm, 2016, 98: 9-19. 被引量:1

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部